The Evidence Base got an in-depth look at Dr. Inma Hernandez's and Dr. Alvaro San-Juan-Rodriguez's JAMA Neurology paper, "Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D." The authors told The Evidence Base, "We hope...our paper will serve as a call to action to address the pressing issue of high and rising drug prices in the USA, thereby maintaining the affordability and access to specialty medications, and the best possible outcomes for patients." Read the interview here.